Since CFTR influences the transport of GSH into bronchial secretions, CF patients with GCLC gene variants associated with greater glutathione production, with class 3–5 mutations, should have higher levels of bronchial secretion glutathione, which is involved in protecting the lungs from oxidant-induced damage. Here, GCLC is linked to cystic fibrosis.